Steven Chan

Steven Chan

Finansdirektör/CFO på ATTOVIA THERAPEUTICS, INC.

Förmögenhet: 20 200 $ per 2026-07-31

54 år
Health Technology
Consumer Durables
Electronic Technology

Profil

Steven Chan is currently Chief Financial Officer at Suzhou Connect Biopharma Co. Ltd. and Chief Financial Officer at Attovia Therapeutics, Inc. Former roles include Chief Financial Officer at Connect Biopharma Holdings Ltd. (2021-2024), Chief Financial Officer at Delphon Industries LLC (2019-2021), Principal Accounting Officer & Controller at Arcus Biosciences, Inc. (2017-2019), Chief Accounting Officer, VP & Controller at MyoKardia, Inc. (2016-2017), Vice President & Controller at Solta Medical, Inc. (2010-2014), Vice President-Finance at Moody's Analytics, Inc. (2007-2010), Director-Worldwide Revenue at Polycom, Inc. (2006-2007), and Controller at Logitech International SA (2002-2006).
Education includes undergraduate studies at Haas School of Business.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2025-03-21 10 000 ( 0,02 % ) 20 200 $ 2026-07-31

Aktiva positioner av Steven Chan

FöretagPositionStart
ATTOVIA THERAPEUTICS, INC. Finansdirektör/CFO 2024-10-01
Finansdirektör/CFO -

Tidigare kända positioner av Steven Chan

FöretagPositionSlut
CONNECT BIOPHARMA HOLDINGS LIMITED Finansdirektör/CFO 2024-09-13
Finansdirektör/CFO 2021-11-01
ARCUS BIOSCIENCES, INC. Comptroller/Controller/Revisor 2019-04-01
MYOKARDIA, INC. Finansdirektör/CFO 2017-03-01
Comptroller/Controller/Revisor 2014-07-01
Se detaljerna i Steven Chans erfarenhet

Steven Chans utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

61

Första gradens relationer

11

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag11

Consumer Durables

Electronic Technology

Health Technology

Process Industries

Commercial Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Steven Chan